z-logo
Premium
Recent advances in the understanding of severe cutaneous adverse reactions
Author(s) -
Adler N.R.,
Aung A.K.,
Ergen E.N.,
Trubiano J.,
Goh M.S.Y.,
Phillips E.J.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15423
Subject(s) - medicine , dermatology , intensive care medicine
Summary Severe cutaneous adverse reactions ( SCAR s) encompass a heterogeneous group of delayed hypersensitivity reactions, which are most frequently caused by drugs. Our understanding of several aspects of SCAR syndromes has evolved considerably over the last decade. This review explores evolving knowledge of the immunopathogenic mechanisms, pharmacogenomic associations, in vivo and ex vivo diagnostics for causality assessment, and medication cross‐reactivity data related to SCAR syndromes. Given the rarity and severity of these diseases, multidisciplinary collaboration through large international, national and/or multicentre networks to collect prospective data on patients with SCAR syndromes should be prioritized. This will further enhance a systematized framework for translating epidemiological, clinical and immunopathogenetic advances into preventive efforts and improved outcomes for patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here